Modern molecular studies have presented many insights to the processes that govern the event and progression of CLL, which includes a lot of novel mutated genes clustered in different purposeful pathways. The CLL epigenome is reprogrammed with the modulation of regulatory locations that show up de novotranslocations or amplifications in addition to